LauraJKlesseMD
Pediatric Hematology & Oncology • Dallas, TXCancer Genetics/Cancer Risk Assessment, Pediatric Neuro-Oncology
Associate Professor, Pediatrics, University of Texas Southwestern Medical Center, Southwestern Medical School
Dr. Klesse is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5323 Harry Hines Blvd
Stop 9063
Dallas, TX 75390Phone+1 214-528-2050Fax+1 214-648-3122
Summary
- Dr. Laura Klesse is a pediatric hematologist/oncologist in Dallas, TX and is affiliated with multiple hospitals in the area, including Children's Medical Center Dallas, University of Texas Southwestern Medical Center, and Children's Medical Center Plano. She received her medical degree from University of Texas Southwestern Medical School and has been in practice 16 years. She specializes in cancer genetics/cancer risk assessment and pediatric neuro-oncology.
Education & Training
University of Texas Southwestern Medical CenterFellowship, Pediatric Hematology/Oncology, 2005 - 2008- University of Texas Southwestern Medical CenterResidency, Pediatrics, 2002 - 2005
University of Texas Southwestern Medical SchoolClass of 2001
Certifications & Licensure
TX State Medical License 2007 - 2026- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Everolimus for Children With Recurrent or Progressive Ependymoma Start of enrollment: 2015 Feb 01
- Evaluation of [18F]FLT PET/CT as an Early Predictor of Outcome in Pediatric Solid Tumors Start of enrollment: 2019 Aug 13
- MEK Inhibitor Mirdametinib (PD-0325901) in Patients With Neurofibromatosis Type 1 Associated Plexiform Neurofibromas Start of enrollment: 2019 Sep 29
- Join now to see all
Publications & Presentations
PubMed
- 33 citationsMEK inhibitors for neurofibromatosis type 1 manifestations: Clinical evidence and consensus.Peter M K de Blank, Andrea M Gross, Srivandana Akshintala, Jaishri O Blakeley, Gideon Bollag
Neuro-Oncology. 2022-11-02 - 129 citationsTrks: signal transduction and intracellular pathways.Laura J. Klesse, Luis F. Parada
Microscopy Research and Technique. 1999-05-15 - 5 citationsInsights into the Pathogenesis of NF1-Associated Neoplasms.Ashley Bui, Chunhui Jiang, Renée M. McKay, Laura J. Klesse, Lu Q. Le
JID Innovations. 2021-08-20
Press Mentions
- Family of Three-Year-Old Cancer Patient Wears Superhero Costumes to Every ChemoMay 3rd, 2022
- ChatGPT Can Extract Data from Clinical NotesMay 9th, 2024
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
